Historical Stock Price
NKTR historical stock prices picture
Nektar Therapeutics (NKTR) has the following price history information. Looking back at NKTR historical stock prices for the last five trading days, on April 19, 2024, NKTR opened at $1.33, traded as high as $1.33 and as low as $1.20, and closed at $1.24. Trading volume was a total of 4.72M shares. On April 22, 2024, NKTR opened at $1.31, traded as high as $1.41 and as low as $1.29, and closed at $1.36. Trading volume was a total of 1.97M shares. On April 23, 2024, NKTR opened at $1.39, traded as high as $1.43 and as low as $1.31, and closed at $1.42. Trading volume was a total of 1.10M shares. On April 24, 2024, NKTR opened at $1.37, traded as high as $1.42 and as low as $1.37, and closed at $1.38. Trading volume was a total of 958.20K shares. On April 25, 2024, NKTR opened at $1.36, traded as high as $1.37 and as low as $1.29, and closed at $1.32. Trading volume was a total of 1.05M shares.

NKTR Historical Stock Prices By Date:

NKTR historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Nektar Therapeutics shares, starting with a $10,000 purchase of NKTR, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/29/2014
End date: 04/25/2024
Start price/share: $11.49
End price/share: $1.32
Dividends collected/share: $0.00
Total return: -88.51%
Average Annual Total Return: -19.46%
Starting investment: $10,000.00
Ending investment: $1,149.14
Years: 10.00
Date Open High Low Close Volume
04/19/2024 $1.33 $1.33 $1.20 $1.24 4.72M
04/22/2024 $1.31 $1.41 $1.29 $1.36 1.97M
04/23/2024 $1.39 $1.43 $1.31 $1.42 1.10M
04/24/2024 $1.37 $1.42 $1.37 $1.38 958.20K
04/25/2024 $1.36 $1.37 $1.29 $1.32 1.05M
Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s research and development pipeline of investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, Co. is studying several immuno-oncology drug candidates including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, Co. is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, Co.'s programs include studying bempegaldesleukin in treating individuals affected with COVID-19, and a preclinical research collaboration with Gilead Sciences Inc. to test the combination of NKTR-255.
Date Close
04/19/2024$1.24
04/22/2024$1.36
04/23/2024$1.42
04/24/2024$1.38
04/25/2024$1.32
NKTR is categorized under the Healthcare sector; below are some other companies in the same sector:

NLNK Historical Stock Prices
NNVC Historical Stock Prices
NOVN Historical Stock Prices
NPC Historical Stock Prices
NPSP Historical Stock Prices
NRCIA Historical Stock Prices
NRCIB Historical Stock Prices
NRI Historical Stock Prices
NRX Historical Stock Prices
NSPH Historical Stock Prices

Also explore: NKTR shares outstanding history

Email EnvelopeFree NKTR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


NKTR Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.